News MS Patients Being Evaluated as Fit to Work, Receiving Lower Benefits, Charities Alert MS Patients Being Evaluated as Fit to Work, Receiving Lower Benefits, Charities Alert by Patricia Silva, PhD | November 10, 2014 Share this article: Share article via email Copy article link Patients who suffer from progressive conditions, such as multiple sclerosis (MS), are submitted to unnecessary evaluations for disability benefits and often denied the full payment of their out-of-work benefits or deemed as fit to work when they are in fact not able. This new perspective was highlighted by a group of health-related charities, including theĀ MS Society, which recently released data about Multiple Sclerosis, employment, and disability in order to call attention to how patients withĀ progressive conditions are largely misunderstoodĀ by benefits assessors. More than a third (36%) of patients suffering from MS, Parkinson’s, motor neuron disease, cystic fibrosis, and rheumatoid arthritis were evaluated as fit for work-related activity, aĀ level of the Employment and Support Allowance (ESA) granted to people who are expected to recover enough and be able to work again. That means that 8,000 people suffering from those diseases are supposed to attend regular interviews with advisers, as well as apply for jobs and prepare for a role in the workforce. The ESA is a benefit design to support people who cannot work due to illnesses or disability, and most beneficiaries are evaluated through aĀ Work Capability Assessment. According to the results, people are placed either on theĀ work-related activity group, or in theĀ support group, in which they do not have to attend interviews. Also, depending on the group, the benefit is different. The first group is paid at a lower rate than the second one, and people who are in the work-related activity ESA may suffer sanctions and see their benefit payment reduced if they don’t attend interviews or other activities. [adrotate group=”4″] In addition, the data revealed that 5,000 from the total of people assessed as fit to work were placed in that group despite the fact that the Work Capability Assessment stated that theirĀ return to employment was “unlikely in the longer term.” The five charities who joined forces to disclose the data are now asking assessors to show medical evidence that justifies placing patients suffering from progressive conditions in the work-related activity group. āIt is unfathomable that people with progressive conditions who are deemed by assessors to be unlikely to return to work in the longer term are still being told to seek employment,” said theĀ Senior Policy and Campaigns Officer at the MS Society,Ā Claire Nurden.Ā “It is vital that additional safeguards are introduced into the assessment process to stop people with MS slipping through the net.ā In addition to the MS Society, Parkinsonās UK, the Motor Neurone Disease Association, National Rheumatoid Arthritis Society, and The Cystic Fibrosis Trust, are all asking assessors to reconsider and place progressive diseases patients in the support group, where they wouldn’t beĀ requiredĀ to attend meetings and would receive the highest payment possible. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags National Multiple Sclerosis Society
April 24, 2024 News by Lindsey Shapiro, PhD Autoantibodies seen in blood years before MS diagnosis: Study
April 23, 2024 News by Mary Chapman Itās year 10 for MSAAās upcoming Improving Lives Benefit for MS
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year